May 16, 2007
HistoRx Announces Issuance of U.S. Patent Covering Core AQUAŽ Technology

February 22, 2007
HistoRx AQUAŽ Technology Identifies Two Biomarkers Linked to Lung Cancer Survival

February 15, 2007
HistoRx Installs AQUA® Technology at UCLA School of Medicine

October 24, 2006
HistoRx Announces First Installations of New Quantitative In Situ Biomarker Analysis Platform

July 18 , 2006
HistoRx Names John Tonkinson, Ph.D., Vice President, Business Development

March 6, 2006
Thomas Gerson Joins HistoRx as CFO and VP as Company Advances Commercialization of Molecular Diagnostic Tests

January 31, 2006
HistoRx, Inc. Moves to Advance the Development and Commercialization of New Quantitative Tissue Based Diagnostic Tests

December 21, 2005
More Accurate, Quantitative Method Reported for Linking Biomarker Expression to Patient Outcomes

November 1, 2005
Dr. Ronald M. Lindsay Joins HistoRx Board of Directors

October 13, 2005
HistoRx and Eli Lilly Enter Into a Collaboration

July 25, 2005
High TRAIL-R2 Expression is Associated With Decreased Breast Cancer Survival

May 2, 2005
HistoRx Moves to State-of-the-Art R&D Complex

February 23, 2005
HistoRx to Unveil HARP™ Program

September 14, 2004
HistoRx Completes Initial Financing